UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000023534
Receipt No. R000027104
Scientific Title Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Date of disclosure of the study information 2016/08/08
Last modified on 2016/08/08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Acronym Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Scientific Title Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Scientific Title:Acronym Screenig for Fabry disease in renal transplant patients(Monitoring of mulberry body and mulberry cell)
Region
Japan

Condition
Condition Fabry disease
Classification by specialty
Medicine in general Endocrinology and Metabolism Nephrology
Urology
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To evaluate the usefulness of mulberry body and mulberry cell as screening test for Fabry disease in renal transplant recipients
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes mulberry body, mulberry cell, alpha-galactosidase A activity
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria renal transplant patients gave written informed consent to participate in the study
Key exclusion criteria None
Target sample size 150

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ayumi Funabiki
Organization Takatsuki General Hospital
Division name Endocrinology and Metabolism
Zip code
Address 1-3-13, Kosobe-cho, Takatsuki, Osaka, Japan
TEL 072-681-3801
Email funabiki@ajk.takatsuki-hp.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name Ayumi Funabiki
Organization Takatsuki General Hospital
Division name Endocrinology and Metabolism
Zip code
Address 1-3-13, Kosobe-cho, Takatsuki, Osaka, Japan
TEL 072-681-3801
Homepage URL
Email funabiki@ajk.takatsuki-hp.or.jp

Sponsor
Institute Takatsuki General Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 06 Month 28 Day
Date of IRB
Anticipated trial start date
2016 Year 08 Month 08 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information To evaluate the usefulness of mulberry body and mulberry cell as screening test for Fabry disease in renal transplant patients

Management information
Registered date
2016 Year 08 Month 08 Day
Last modified on
2016 Year 08 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027104

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.